134 related articles for article (PubMed ID: 14659336)
1. Prognosis of bilateral synchronous breast cancer in Vaud, Switzerland.
Levi F; Randimbison L; Te VC; La Vecchia C
Breast; 2003 Apr; 12(2):89-91. PubMed ID: 14659336
[TBL] [Abstract][Full Text] [Related]
2. Synchronous, bilateral breast cancer: prognostic value and incidence.
Jobsen JJ; van der Palen J; Ong F; Meerwaldt JH
Breast; 2003 Apr; 12(2):83-8. PubMed ID: 14659335
[TBL] [Abstract][Full Text] [Related]
3. Bilateral Breast Cancer After Multimodality Treatment: A Report of Clinical Outcomes in an Asian Population.
Wadasadawala T; Lewis S; Parmar V; Budrukkar A; Gupta S; Nair N; Shet T; Badwe R; Sarin R
Clin Breast Cancer; 2018 Aug; 18(4):e727-e737. PubMed ID: 29254601
[TBL] [Abstract][Full Text] [Related]
4. The long-term outcome of synchronous bilateral breast cancer is worse than metachronous or unilateral tumours.
Carmichael AR; Bendall S; Lockerbie L; Prescott R; Bates T
Eur J Surg Oncol; 2002 Jun; 28(4):388-91. PubMed ID: 12099647
[TBL] [Abstract][Full Text] [Related]
5. Bilateral breast cancer, synchronous and metachronous; differences and outcome.
Jobsen JJ; van der Palen J; Ong F; Riemersma S; Struikmans H
Breast Cancer Res Treat; 2015 Sep; 153(2):277-83. PubMed ID: 26268697
[TBL] [Abstract][Full Text] [Related]
6. Properties of Synchronous Versus Metachronous Bilateral Breast Carcinoma with Long Time Follow Up.
Eliyatkin N; Zengel B; Yagci A; Comut E; Postaci H; Uslu A; Aktas S
Asian Pac J Cancer Prev; 2015; 16(12):4921-6. PubMed ID: 26163616
[TBL] [Abstract][Full Text] [Related]
7. Survival of patients with bilateral versus unilateral breast cancer and impact of guideline adherent adjuvant treatment: a multi-centre cohort study of 5292 patients.
Schwentner L; Wolters R; Wischnewsky M; Kreienberg R; Wöckel A
Breast; 2012 Apr; 21(2):171-7. PubMed ID: 21945313
[TBL] [Abstract][Full Text] [Related]
8. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease.
Heron DE; Komarnicky LT; Hyslop T; Schwartz GF; Mansfield CM
Cancer; 2000 Jun; 88(12):2739-50. PubMed ID: 10870056
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of synchronous and metachronous bilateral breast cancer.
Kollias J; Ellis IO; Elston CW; Blamey RW
World J Surg; 2001 Sep; 25(9):1117-24. PubMed ID: 11571945
[TBL] [Abstract][Full Text] [Related]
10. [The prognosis of bilateral breast carcinoma compared to unilateral breast tumor. 5- and 10-year follow-ups].
Mose S; Adamietz IA; Thilmann C; Saran F; Pahnke R; Böttcher HD
Strahlenther Onkol; 1995 Apr; 171(4):207-13. PubMed ID: 7740408
[TBL] [Abstract][Full Text] [Related]
11. Second primary cancers in the Vaud and Neuchâtel Cancer Registries.
Levi F; Randimbison L; Rafael BM; Manuela MC; La Vecchia C
Eur J Cancer Prev; 2015 Mar; 24(2):150-4. PubMed ID: 25397586
[TBL] [Abstract][Full Text] [Related]
12. Comparison of prognosis and clinical features between synchronous bilateral and unilateral breast cancers.
Karakas Y; Kertmen N; Lacin S; Aslan A; Demir M; Ates O; Aksoy S; Altundag K
J BUON; 2017; 22(3):623-627. PubMed ID: 28730766
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of early-stage synchronous bilateral invasive breast cancer.
Schmid SM; Pfefferkorn C; Myrick ME; Viehl CT; Obermann E; Schötzau A; Güth U
Eur J Surg Oncol; 2011 Jul; 37(7):623-8. PubMed ID: 21628090
[TBL] [Abstract][Full Text] [Related]
14. pCR rates in patients with bilateral breast cancer after neoadjuvant anthracycline-taxane based-chemotherapy - A retrospective pooled analysis of individual patients data of four German neoadjuvant trials.
Reinisch M; Huober J; von Minckwitz G; Blohmer JU; Denkert C; Hanusch C; Jackisch C; Kümmel S; Schneeweiss A; Rhiem K; Lederer B; Untch M; Nekljudova V V; Loibl S
Breast; 2017 Apr; 32():73-78. PubMed ID: 28063331
[TBL] [Abstract][Full Text] [Related]
15. Bilateral breast cancers in an Asian population, and a comparison between synchronous and metachronous tumours.
Sim Y; Tan VKM; Sidek NAB; Chia DKA; Tan BKT; Madhukumar P; Yong WS; Wong CY; Ong KW
ANZ J Surg; 2018 Oct; 88(10):982-987. PubMed ID: 30141242
[TBL] [Abstract][Full Text] [Related]
16. Impact of bilateral breast cancer on prognosis: synchronous versus metachronous tumors.
Ibrahim NY; Sroor MY; Darwish DO
Asian Pac J Cancer Prev; 2015; 16(3):1007-10. PubMed ID: 25735321
[TBL] [Abstract][Full Text] [Related]
17. The prognostic comparison among unilateral, bilateral, synchronous bilateral, and metachronous bilateral breast cancer: A meta-analysis of studies from recent decade (2008-2018).
Pan B; Xu Y; Zhou YD; Yao R; Wu HW; Zhu QL; Wang CJ; Mao F; Lin Y; Shen SJ; Sun Q
Cancer Med; 2019 Jun; 8(6):2908-2918. PubMed ID: 31038845
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic variables and survival comparison of patients with synchronous endometrial and ovarian cancers versus primary endometrial cancer with ovarian metastasis.
Oranratanaphan S; Manchana T; Sirisabya N
Asian Pac J Cancer Prev; 2008; 9(3):403-7. PubMed ID: 18990010
[TBL] [Abstract][Full Text] [Related]
19. [Bilateral breast carcinoma. 12 years' experience].
Maculotti L; Gandini F; Pradella P
Minerva Chir; 1996; 51(1-2):33-7. PubMed ID: 8677043
[TBL] [Abstract][Full Text] [Related]
20. Survival from synchronous bilateral breast cancer: the experience of surgeons participating in the breast audit of the Society of Breast Surgeons of Australia and New Zealand.
Roder D; de Silva P; Zorbas H; Kollias J; Malycha P; Pyke C; Campbell I; Webster F
Asian Pac J Cancer Prev; 2012; 13(4):1413-8. PubMed ID: 22799341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
